Hikma
Focus: Hikma is a specialty pharmaceutical company headquartered in Berkeley Heights, NJ, focused on medication delivery across oncology, infectious diseases, cardiovascular, neurology, and immunology. The company operates primarily in generics and specialty generics with a diversified but revenue-concentrated portfolio.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Hikma
AI assessmentNot HiringNo open roles listed right now. Follow Hikma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Hikma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
1 imminent
ONSOLIS
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$108M Part DDeclining
Post-LOE
Cash-cow generics product representing 34% of company revenue; established calcium channel blocker with mature market but ongoing price pressure from competitors.
Help build intelligence for Hikma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.